Detalhe da pesquisa
1.
A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer.
Eur J Nucl Med Mol Imaging
; 48(1): 95-102, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32458006
2.
Prognostic value of 18F-FDG uptake by regional lymph nodes on pretreatment PET/CT in patients with resectable colorectal cancer.
Eur J Nucl Med Mol Imaging
; 41(12): 2203-11, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24990406
3.
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹8F-FDG PET/CT and MRI.
Eur J Nucl Med Mol Imaging
; 41(8): 1553-62, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24652233
4.
The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 41(10): 1852-60, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24927797
5.
¹8F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.
Eur J Nucl Med Mol Imaging
; 40(5): 728-36, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23361860
6.
Prognostic significance of pretreatment ¹8F-FDG PET/CT in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma treated by radioimmunotherapy using ¹³¹I-rituximab.
Acta Haematol
; 130(2): 74-82, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23548464
7.
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma.
Skeletal Radiol
; 42(12): 1673-81, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23995264
8.
A Phase II Study of 131I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma.
Clin Med Insights Oncol
; 17: 11795549231218082, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38090634
9.
Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
Asia Pac J Clin Oncol
; 19(6): 690-696, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915956
10.
The Feasibility of 64Cu-PSMA I&T PET for Prostate Cancer.
Cancer Biother Radiopharm
; 37(6): 417-423, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33434438
11.
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.
PLoS One
; 17(9): e0273839, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156599
12.
The Prediction of HER2-Targeted Treatment Response Using 64Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report.
J Breast Cancer
; 25(1): 69-73, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133094
13.
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer.
EJNMMI Res
; 11(1): 8, 2021 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475899
14.
A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor.
Clin Nucl Med
; 46(9): 717-722, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034333
15.
Early response monitoring of neoadjuvant chemotherapy using [18F]FDG PET can predict the clinical outcome of extremity osteosarcoma.
EJNMMI Res
; 10(1): 1, 2020 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31900594
16.
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning.
Sci Rep
; 10(1): 21149, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273490
17.
Clinical Usefulness of 18F-FC119S Positron-Emission Tomography as an Auxiliary Diagnostic Method for Dementia: An Open-Label, Single-Dose, Evaluator-Blind Clinical Trial.
J Clin Neurol
; 16(1): 131-139, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942769
18.
An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy.
Ann Nucl Med
; 33(2): 128-134, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30382500
19.
Comparisons of 131I-rituximab treatment responses in patients with aggressive lymphoma and indolent lymphoma.
Ann Nucl Med
; 33(12): 881-890, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571043
20.
Anesthesia condition for (18)F-FDG imaging of lung metastasis tumors using small animal PET.
Nucl Med Biol
; 35(1): 143-50, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18158953